Biophytis【ALBPS】銘柄情報

Biophytis (ALBPS) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.0153

( - )

買値

0.0102

売値

0.0155

出来高

0.00

0.00 日の範囲 0.00

0.0153 52 週間の範囲 0.196

時価総額

1.402M

前日終値

0.0153

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

5,037,409 €

発行済株式数

91,622,088

配当利回り

PER

-0.02

1 株当たり利益 (EPS)

-0.61

歳入

純利益

-8.03M

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases. The company’s lead drug candidate is the BIO101 to treat obesity, respiratory infections due... Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases. The company’s lead drug candidate is the BIO101 to treat obesity, respiratory infections due to Covid-19, sarcopenia, and Duchenne Muscular Dystrophy (DMD). It has a collaboration agreement with AFM-Telethon for the development of its BIO101 for the treatment of DMD. It also has an alliance with LynxKite Technologies Pte Ltd for the development of AI-driven drug discovery for longevity therapies. The company was incorporated in 2006 and is headquartered in Paris, France. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.biophytis.com

本社

Paris, France

設立

2026

Biophytis is listed in the Healthcare sector of the ユーロネクスト with ticker ALBPS. The last closing price for Biophytis was 0.02 €. Over the last year, Biophytis shares have traded in a share price range of 0.0153 € to 0.196 €.

Biophytis currently has 91,622,088 shares in issue. The market capitalisation of Biophytis is 1.40 € million. Biophytis has a price to earnings ratio (PE ratio) of -0.02.

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

ADRs Close Lower; Fanhua Slips 16%

This article was automatically generated by MarketWatch using technology from Automated Insights. International stocks trading in New York closed...

Biophytis Shares Drop 11% After Request for Meeting With FDA on Covid-19 Treatment

By Chris Wack Biophytis shares fell 11% to $2.40 after the company said it has filed for a pre-submission meeting request with the Food and Drug...

Biophytis to Restate Previously Issued Financial Statements

PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth...

Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patien...

PARIS and CAMBRIDGE, Mass., July 02, 2020 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.0153	0.0153	0.0153	0	0	DE
4	-0.0035	-18.6170212766	0.0188	0.0199	0.0153	922252	0.01691508	DE
12	-0.0016	-9.4674556213	0.0169	0.0327	0.0153	4102205	0.02136673	DE
26	-0.0447	-74.5	0.06	0.1098	0.0153	3122202	0.02867031	DE
52	-0.1157	-88.320610687	0.131	0.196	0.0153	1735560	0.03663873	DE
156	-0.0047	-23.5	0.02	1.4	0.0021	5283668	0.01288818	DE
260	-0.7713	-98.0549199085	0.7866	1.4	0.0021	4090844	0.04883942	DE